Initial test to diagnose or rule out Ehlers-Danlos Syndrome, Type VI A (kyphoscoliotic type). This testing is NOT recommended to screen for other types of EDS.
High Performance Liquid Chromatography (HPLC)
New York DOH Approval Status
First-morning urine is preferred.
Urine. First-morning void. Also acceptable: Random specimens.
Transfer 4 mL urine to an ARUP Standard Transport Tube. (Min: 3 mL)
Ambient: Unacceptable; Refrigerated: 1 week; Frozen: 6 months
|0-11 months||Not applicable||Not applicable||0.13-0.20|
|1-3 years||Not applicable||Not applicable||0.18-0.24|
|4-9 years||Not applicable||Not applicable||0.19-0.25|
|10-14 years||Not applicable||Not applicable||0.17-0.27|
|15-19 years||Not applicable||Not applicable||0.20-0.26|
|20 years and older||Not applicable||Not applicable||0.23-0.29|
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
For pyridinoline and deoxypyridinoline quantitative results, order Pyridinoline & Deoxypyridinoline by HPLC (0080342).
|Component Test Code*||Component Chart Name||LOINC|
- EDS VI
- pyridinoline and deoxypyridnoline